Eliminating hepatitis C
The Health Care Authority (HCA) is partnering with the Department of Health (DOH) and AbbVie US LLC, a research-based global biopharmaceutical company, in an effort to eliminate hepatitis C (HCV) in Washington State by 2030.
On this page
Learn more about eliminating hepatitis C in Washington.
HCA, DOH and AbbVie are coordinating efforts to find individuals who are not yet treated; educate the health care workforce about screening and providing curative HCV treatment; and address barriers to care such as stigma, access to HCV providers, and the lack of urgency to treat among patients and providers.
In order to achieve HCV elimination in Washington State, DOH convened partners and stakeholders to develop the Hep C Free Washington plan. These include:
- People affected by HCV
- Local health jurisdictions
- Tribal Nations
- Medical providers
- Others with an interest in HCV elimination
Action! This is a huge opportunity to rid our state of the most common blood borne disease in the United States – and now it is possible.
Effective immediately, we would like all providers licensed to treat HCV to screen and treat the target population. In order to support our provider community in this monumental effort, Apple Health (Medicaid) has made important policy changes:
- The antiviral Mavyret™ no longer requires prior authorization (PA). Other direct-acting antivirals will require review and will be approved only when Mavyret™ is not clinically appropriate.
- Anyone licensed to prescribe direct acting antiviral medications is allowed to screen and treat Apple Health members to support this effort.
HCA has launched a webinar series dedicated to highlighting efforts to eliminate HCV in Washington State.
|Time and date (Pacific)||Registration||Agenda|
November 6, 2020
Listen at your convenience
|HCA webinar series recording:
Myth busting: treating hepatitis C in primary care
Presenter: John Scott, MD, MSc
October 6, 2020
Listen at your convenience
HCA webinar series recording:
HCA and AbbVie deployed an HCV elimination awareness bus to areas of Washington State with high-risk HCV populations. This strategy is part of a national program to educate the population about the importance of screening and linkage to care. When a person visits the bus, they are able to get hep C antibody testing to determine if they may have the virus.
2022 bus stops
|October 8||Family Medical Health Fair||
Time: 10 a.m. – 2 p.m.
Location: 1120 West Rose Street Walla Walla, WA 99362
|October 7||Project Homeless Connect||
Time: 11 a.m. – 3 p.m.
Location: The Church Jesus Christ of Latter Day Saints, 1102 South Pearl St, Tacoma, WA 98465
- AASLD-IDSA Simplified HCV Guidelines (without Cirrhosis)
- AASLD-IDSA Simplified HCV Guidelines (with Compensated Cirrhosis)
- CDC viral hepatitis guidelines
- Frequently asked questions (FAQ)
- AbbVie Quick Reference Guide
- Pharmacy notice - Apple Health billing
- Provider cheat sheet
- Mavyret™ nurse ambassador program
- Hepatitis C Online (uw.edu)
- Project ECHO Flyer 2022-2023.pdf (uwmedicine.org)